Click on headlines below to download research

Resilient business model in a challenging market
Thrace Group | 21/06/2023

Thrace Group’s Q123 results highlight continued growth in underlying adjusted EBITDA (excluding personal protective equipment (PPE) related products),…

Demonstrable core growth as COVID-19 subsides
Thrace Group | 13/04/2023

Thrace Plastics’ FY22e core product PBT (excluding the c €5m pandemic-related personal protective equipment (PPE) boost and one-off financial…

Maintaining a steady course
Thrace Plastics | 06/12/2021

Thrace delivered another strong profit contribution in Q3, even after the expected slowdown in sales volumes to the medical subsector. This ongoing sector…